The most well-characterized epigenetic changes are the heritable transcriptional silencing of tumor suppressor genes (TSGs) 4 by aberrant CpG DNA hypermethylation of their promoters (1, 2 ) . The effect of such promoter methylation is similar to loss-of-function genetic mutations and has been observed at wellcharacterized TSGs that cause inherited forms of cancer when mutated in germline events (3) (4) (5) . Because methylation-based gene inactivation can occur very early during cancer progression, even before mutations are observed, detecting DNA methylation may be useful for early cancer detection (6 -8 ) . In recent years, several approaches have been designed to detect and differentiate methylated sequences in nonpathologic and cancer tissues. First-generation methods were based primarily on the use of methylation-sensitive restriction enzymes followed by Southern blotting (9 ) . Second-generation methods include approaches that are focused on either discovering regions that are differentially methylated in nonpathologic and cancer tissues or analyzing the methylation profile of candidate TSGs (8, 10, 11 ) . These techniques can be broadly classified into (a) CpG-detection methods, including methylation-specific PCR (MSP), quantitative MSP, and nested MSP; (b) detailed analysis of specific patterns of CpG methylation, as in bisulfite sequencing, for example; and (c) genomewide approaches that use array-based detection, such as with the Illumina system (12 ), or gene expression analyses to identify genes that are expressed upon the reversal of epigenetic modifications by pharmacologic agents (13 ) . Most of these methods include DNA extraction followed by sodium bisulfite conversion (14 ) of the denatured template DNA. Conventional DNA extraction typically involves chemical lysis of cells followed by phenol-chloroform extraction and ethanol precipitation (PC), which requires both centrifugation and air-drying (15 ) . The extracted DNA is then subjected to sodium bisulfite conversion, which requires denaturation of genomic DNA, deamination of unmethylated cytosines with a high sodium bisulfite concentration, and desulfonation with a strong base. The temperature, pH, and salt concentra-tion all require careful calibration, and the recommended time for efficient bisulfite conversion is 12-16 h (11 ) . High DNA yield and quality, as well as proper efficiency in the bisulfite treatment, are prerequisites for these techniques to function well.
Given these multiple steps, conventional methods are relatively laborious compared with methods of DNA extraction on a solid substrate, in which DNA binds to a silica surface in solutions containing chaotropic salts, such as those of iodide or perchlorate (16 ) . Although solid-substrate methods have been implemented to simplify the process, methylation analysis is still a disjointed process in which DNA extraction, bisulfite conversion, and the PCR are carried out in separate tubes. The methylation-on-beads (MOB) technique addresses this problem as a single-tube methylation-detection method (see Fig. 1 in the Data Supplement that accompanies the online version of this Brief Communication at http://www.clinchem. org/content/vol56/issue6). MOB begins with cell lysates or patient samples mixed with silica superparamagnetic beads (SSBs) (17 ) in a chaotropic solution of guanidine HCl in citric acid buffer, which promotes binding of DNA to SSBs. Remaining unbound in the solution are other macromolecules and cell debris, which are then removed by extracting the liquid phase. Additional washing steps with alcohol are required to ensure adequate DNA purity for subsequent analysis. The bound DNA is then eluted in a buffer of low ionic strength and used for the next step in this process (see Table 1 and Supplemental Methods in the online Data Supplement). The MOB protocol can be completed in 9 h, from DNA isolation to methylation analysis with MSP, quantitative MSP, or methylation-specific quantum dot fluorescence resonance energy transfer (MSqFRET) (18 ) .
The enhancement of pre-PCR DNA yields with MOB is due to a combination of processes. The large surface area of SSBs allows large amounts of DNA to be captured, minimization of the washing/binding steps decreases DNA loss at each step, and single-tube processing reduces the DNA loss that occurs during tube transfers. An insufficient DNA yield represents a challenge for the development of blood-based biomarkerdetection systems. To illustrate the advantage of a single-tube process, we compared pre-PCR yield and methylation detection with the MOB approach with the conventional PC/bisulfite conversion/MSP assay. We carried out a representative comparative analysis with 15 serum samples from lung cancer patients (7 stage I, 3 stage II, and 5 stage III patients) (Fig. 1) . Recovery with MOB was greater than for PC/bisulfite conversion for each patient serum sample (median increase, 6.61-fold). Extraction yields were higher with the MOB method than with commercial kits meant for DNA extraction (see Fig. 2A in the online Data Supplement). The analysis was extended to 10 more samples, including fresh tissue and paraffin-embedded tissue from healthy patients, fresh tumor tissues from cancer patients, and sputum samples. Increases in median DNA yield of 7.8-, 5.3-, 6.4-, and 7.5-fold, respectively, were obtained with MOB, compared with the conventional PC/bisulfite conversion method (see Fig. 2B in the online Data Supplement).
Apart from being a single-tube process, this technique has the unique feature of combining deamination and desulfonation, a simplification from the conventional approach, which requires binding and washing steps between these 2 processes. Minimizing the number of binding and washing steps further increases the DNA yield and reduces the assay time (data not shown). In addition, the technique uses SSBs within the tube for both the bisulfite-conversion process and the PCR. To demonstrate that the presence of SSBs does not hinder bisulfite conversion, we used realtime MSP to evaluate CDKN2A 5 [cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); also known as p16 INK4a ] promoter methylation. We evaluated 5 triplicate reactions with input DNA from varying bisulfite treatment durations (0, 1, 3, 4, and 8 h) and compared the results with those for the control, which used 16 h of conventional bisulfite treatment (see Supplemental Methods in the online Data Supplement). The results indicate that 4 h of bisulfite treatment is sufficient for conversion and that the presence of beads does not alter the conversion process (see 5 Human genes: CDKN2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); CDKN2B; cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); PYCARD, PYD and CARD domain containing. Yields have been normalized for an input of 25 L of serum. Fig. 3 in the online Data Supplement). Furthermore, the ability to generate precise real-time quantitative methylation results and reproducible PCR products also illustrates that the beads are not detrimental to the PCR. The sources of DNA in serum are still unknown but are likely to include both circulating tumor cells and free DNA released from tumor masses. Assessment of methylation in serum or plasma can therefore be a useful tool for the early detection of cancer. Several studies have demonstrated hypermethylationassociated inactivation of CDKN2A as an early and frequent event in non-small-cell lung cancers (squamous cell carcinoma, 60%-80%; adenocarcinoma, 30%-45%) and other cancers (19 -21 ) . Although most of these studies have used MSP as an analytical tool to assess gene methylation, extending such an analysis to clinically usable serum-and blood-based tests has been limited by the lack of sensitivity of previous methods. To address directly whether improving DNA yields can affect methylation detection, we compared the MOB and the conventional PC/bisulfite/MSP approaches in a blinded study to evaluate methylation of the CDKN2A promoter in 49 patient serum samples (18 nonpathologic and 31 cancer samples). The 31 tumor samples were preselected from patients with diagnosed lung cancer who also showed CDKN2A promoter methylation in the corresponding tumors. The primers and methods used are described in detail in the Supplemental Methods and Table 2 of the online Data Supplement. Whereas CDKN2A methylation was detected in 14 of 31 lung cancer patients with the conventional PC/bisulfite/MSP technique, the MOB method was able to detect CDKN2A methylation in 23 of these 31 patients (see Table 3 in the online Data Supplement).
When samples used for methylation analysis contain large amounts of DNA (i.e., cell lines, tumors, and so forth), a single-tube analysis of the entire input amount may be unnecessary; however, MOB permits storage of either the extracted DNA or the bisulfitetreated DNA, which can be used later for downstream analyses. In addition, conducting multiple reactions in parallel is feasible with the MOB approach because it allows direct splitting of the magnetic beads into several tubes. We tested the MOB method with colorectal cancer cell line RKO and obtained yields of extracted DNA of 20 -60 g. After splitting the SSB-bound DNA into 10 different tubes, we still had sufficient material for successful MSP analysis of the CDKN2A, CDKN2B [cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)], and PYCARD (PYD and CARD domain containing; also known as ASC and TMS1) promoters (data not shown).
This magnetically actuated single-tube methylation analysis system with SSBs should be automatable and compatible with commercial available robots that use magnetic capture, because reagents are siphoned into and out of the single tube in a similar manner and because the binding and elution processes are consistent. The introduction of SSBs simplifies sample handling; bypasses the use of liquid transfer, air-drying, and centrifugation; and increases yields over those of conventional methods. The SSBs present in the tube do not hinder bisulfite conversion, MSP, or other methods [including MS-qFRET (18 ) ], a feature that can further enhance analytical sensitivity through nanotechnologybased detection (see Fig. 4 in the online Data Supplement). Minimizing binding and washing steps by combining deamination and desulfonation can further improve efficiency. Given that the process can be completed in as little as 9 h, the method presents a viable way for clinically implementing methylation analysis.
